» Articles » PMID: 22665991

Soluble Host Defense Lectins in Innate Immunity to Influenza Virus

Overview
Specialty Biology
Date 2012 Jun 6
PMID 22665991
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Host defenses against viral infections depend on a complex interplay of innate (nonspecific) and adaptive (specific) components. In the early stages of infection, innate mechanisms represent the main line of host defense, acting to limit the spread of virus in host tissues prior to the induction of the adaptive immune response. Serum and lung fluids contain a range of lectins capable of recognizing and destroying influenza A viruses (IAV). Herein, we review the mechanisms by which soluble endogenous lectins mediate anti-IAV activity, including their role in modulating IAV-induced inflammation and disease and their potential as prophylactic and/or therapeutic treatments during severe IAV-induced disease.

Citing Articles

Mineralo-organic particles inhibit influenza A virus infection by targeting viral hemagglutinin activity.

Chiang H, Peng H, Weng K, Hsiung K, Liang C, Kuo S Nanomedicine (Lond). 2024; 19(28):2375-2390.

PMID: 39320315 PMC: 11492690. DOI: 10.1080/17435889.2024.2403326.


Immune Control of Avian Influenza Virus Infection and Its Vaccine Development.

Dey P, Ahuja A, Panwar J, Choudhary P, Rani S, Kaur M Vaccines (Basel). 2023; 11(3).

PMID: 36992177 PMC: 10058720. DOI: 10.3390/vaccines11030593.


Targeting undruggable carbohydrate recognition sites through focused fragment library design.

Shanina E, Kuhaudomlarp S, Siebs E, Fuchsberger F, Denis M, Gomes P Commun Chem. 2023; 5(1):64.

PMID: 36697615 PMC: 9814205. DOI: 10.1038/s42004-022-00679-3.


Protein-bound sialic acid in saliva contributes directly to salivary anti-influenza virus activity.

Kobayashi K, Shono C, Mori T, Kitazawa H, Ota N, Kurebayashi Y Sci Rep. 2022; 12(1):6636.

PMID: 35459785 PMC: 9033866. DOI: 10.1038/s41598-022-10559-4.


Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.

Hsieh M, Beirag N, Murugaiah V, Chou Y, Kuo W, Kao H Front Immunol. 2021; 12:641360.

PMID: 34054808 PMC: 8161545. DOI: 10.3389/fimmu.2021.641360.


References
1.
Eda S, Suzuki Y, Kawai T, Ohtani K, Kase T, Fujinaga Y . Structure of a truncated human surfactant protein D is less effective in agglutinating bacteria than the native structure and fails to inhibit haemagglutination by influenza A virus. Biochem J. 1997; 323 ( Pt 2):393-9. PMC: 1218332. DOI: 10.1042/bj3230393. View

2.
van Eijk M, White M, Batenburg J, Vaandrager A, van Golde L, Haagsman H . Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. Am J Respir Cell Mol Biol. 2003; 30(6):871-9. DOI: 10.1165/rcmb.2003-0355OC. View

3.
Ikegami M, Na C, Korfhagen T, Whitsett J . Surfactant protein D influences surfactant ultrastructure and uptake by alveolar type II cells. Am J Physiol Lung Cell Mol Physiol. 2004; 288(3):L552-61. DOI: 10.1152/ajplung.00142.2004. View

4.
Hughes A . Evolution of the lung surfactant proteins in birds and mammals. Immunogenetics. 2007; 59(7):565-72. DOI: 10.1007/s00251-007-0218-6. View

5.
Takahashi M, Mori S, Shigeta S, Fujita T . Role of MBL-associated serine protease (MASP) on activation of the lectin complement pathway. Adv Exp Med Biol. 2007; 598:93-104. DOI: 10.1007/978-0-387-71767-8_8. View